Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Seligman, S. Ribeiro, R. Kuchenbecker, L. Konckewicz, D. Vieira, R. Santos, B. Afonso, D. Machado (Porto Alegre, Brazil). Implementation of evidence based strategies for prevention of ventilator-associated pneumonia. Eur Respir J 2008; 32: Suppl. 52, 2304

Member's Comments

No comment yet.

Related content which might interest you: VAP prevention: pharmacological strategies Source: Eur Respir Mon 2011; 53: 74-82 Year: 2011 Update on therapeutic strategies in community-acquired pneumonia    Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Evidence on measures for the prevention of ventilator-associated pneumonia Source: Eur Respir J 2007; 30: 1193-1207 Year: 2007 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 Management of community-acquired pneumonia: new evidence-based algorithms. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Source: Eur Respir J 2011; 39: 7-8 Year: 2012 Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Source: Eur Respir J 2012; 39: 7-8 Year: 2012 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: Guideline 2018 Year: 2019 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018 Year: 2018 Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines Source: Eur Respir J 2003 Dec 01;22(6):876-882 Year: 2003 Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 Prevention is better than cure: time to change the focus of community-acquired pneumonia management Source: Eur Respir J 2015; 45: 1524-1525 Year: 2015 Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances Year: 2011 Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008